Medications for Bacterial Conjunctivitis

16 results
  • Besivance

    (Besifloxacin)
    Bausch & Lomb Incorporated
    Usage: BESIVANCE (besifloxacin ophthalmic suspension) 0.6% is indicated for the treatment of bacterial conjunctivitis caused by susceptible bacteria, including Haemophilus influenzae and various Staphylococcus, Streptococcus, and Moraxella species. Efficacy for some organisms was studied in fewer than 10 infections.
  • A-S Medication Solutions
    Usage: BESIVANCE (besifloxacin ophthalmic suspension) 0.6% is indicated for treating bacterial conjunctivitis caused by susceptible bacteria, including strains of Staphylococcus, Streptococcus, Pseudomonas, and others. Efficacy details vary by specific organisms, with some studied in fewer than 10 infections.
  • Ciloxan (ciprofloxacin hydrochloride)

    (ciprofloxacin hydrochloride)
    Sandoz Inc
    Usage: CILOXAN® (ciprofloxacin ophthalmic ointment) 0.3% is indicated for treating bacterial conjunctivitis caused by susceptible strains of Gram-positive bacteria (e.g., Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae) and Gram-negative bacteria (e.g., Haemophilus influenzae).
  • Pack Pharmaceuticals, LLC
    Usage: Ciprofloxacin Ophthalmic Solution is indicated for treating infections in the eye caused by susceptible strains of bacteria, notably for corneal ulcers (e.g., Pseudomonas aeruginosa, Staphylococcus aureus) and conjunctivitis (e.g., Haemophilus influenzae, Streptococcus pneumoniae).
  • LUPIN LIMITED
    Usage: Gatifloxacin ophthalmic solution, 0.5% is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of aerobic Gram-positive bacteria (e.g., Staphylococcus aureus) and aerobic Gram-negative bacteria (e.g., Haemophilus influenzae).
  • REMEDYREPACK INC.
    Usage: Gentamicin Sulfate Ophthalmic Solution is indicated for the topical treatment of ocular bacterial infections, including conjunctivitis, keratitis, and corneal ulcers, caused by susceptible strains of bacteria such as Staphylococcus, Streptococcus, E. coli, Haemophilus, Neisseria, Pseudomonas, and Serratia.
  • Advagen Pharma Limited
    Usage: Levofloxacin ophthalmic solution is indicated for treating bacterial conjunctivitis caused by susceptible strains of Gram-positive bacteria (e.g., Staphylococcus, Streptococcus) and Gram-negative bacteria (e.g., Haemophilus, Acinetobacter). Efficacy for some organisms was evaluated in fewer than 10 infections.
  • DIRECT RX
    Usage: Moxifloxacin Ophthalmic Solution is indicated for treating bacterial conjunctivitis caused by various susceptible bacteria, including Staphylococcus, Streptococcus, Haemophilus, Chlamydia, and specific Corynebacterium and Acinetobacter species, with limited efficacy data for some organisms.
  • Redpharm Drug
    Usage: Moxifloxacin ophthalmic solution, 0.5% is indicated for treating bacterial conjunctivitis caused by susceptible strains of various organisms, including Staphylococcus, Streptococcus, Haemophilus, and Chlamydia species. Efficacy for some organisms was studied in fewer than 10 infections.
  • Asclemed USA, Inc.
    Usage: Moxifloxacin ophthalmic solution is indicated for treating bacterial conjunctivitis caused by susceptible strains of various organisms, including Corynebacterium species, Staphylococcus species, Streptococcus pneumoniae, Acinetobacter lwoffii, Haemophilus species, and Chlamydia trachomatis.